Bradley Massey
Family Medicine · Troy, MONPI 1639164502
Payments from drug & device makers
Across 115 payments — averaging $18.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$481
- Novo Nordisk$272
- Dexcom, Inc.$199
- Lilly USA, LLC$143
- Pfizer$111
- Cranial Technologies, Inc$70
- plus $795 from 24 others
What the payments were for
- Food & beverage$2,070100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $481 |
| Novo Nordisk | 16 | $272 |
| Dexcom, Inc. | 7 | $199 |
| Lilly USA, LLC | 7 | $143 |
| Pfizer | 6 | $111 |
| Cranial Technologies, Inc | 3 | $70 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $70 |
| Amgen | 4 | $67 |
| AstraZeneca | 4 | $60 |
| Boehringer Ingelheim | 3 | $58 |
| Novartis | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Bayer | 2 | $41 |
| GSK | 3 | $40 |
| Viatris Specialty LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Mylan Specialty L.p. | 2 | $28 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Abbott | 1 | $25 |
| Alkermes, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 2 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Merck | 1 | $16 |
| Noven Therapeutics, LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
How this compares
$2,070 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 153 | $159,025 |
| JardianceEmpagliflozin | 105 | $114,714 |
| OzempicSemaglutide | 49 | $79,262 |
| MyrbetriqMirabegron | 62 | $48,488 |
| MounjaroTirzepatide | 37 | $46,022 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 32 | $33,352 |
| XareltoRivaroxaban | 29 | $32,129 |
| FarxigaDapagliflozin Propanediol | 36 | $31,087 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $28,008 |
| TrulicityDulaglutide | 11 | $27,580 |
| SymbicortBudesonide/Formoterol Fumarate | 64 | $18,682 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $15,208 |
| InvokanaCanagliflozin | 14 | $13,354 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $13,058 |
| RybelsusSemaglutide | 12 | $11,915 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $111 | $167,994185 claims |
| Boehringer IngelheimJardiance | $58 | $114,714105 claims |
| Novo NordiskOzempic, Rybelsus | $272 | $91,17761 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort | $60 | $83,121132 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $143 | $80,39459 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $40 | $58,97078 claims |
| Astellas Pharma US IncMyrbetriq | $18 | $48,48862 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Troy
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.